12:00 AM
Jan 23, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

DPK-060: Phase II started

Pergamum began a double-blind, placebo-controlled, Swedish Phase II trial to evaluate thrice-daily DPK-060 2% ear drops for 7-10...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >